Pressure BioSciences, Inc. (PBIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 22.75 Million USD | 11.48% |
| 2022 | 20.52 Million USD | 40.21% |
| 2021 | 14.64 Million USD | 52.59% |
| 2020 | 9.59 Million USD | 20.62% |
| 2019 | 7.95 Million USD | 58.96% |
| 2018 | 5 Million USD | -61.99% |
| 2017 | 13.16 Million USD | 138.89% |
| 2016 | 5.51 Million USD | 1184.96% |
| 2015 | 428.97 Thousand USD | -60.46% |
| 2014 | 1.08 Million USD | 129.89% |
| 2013 | 471.96 Thousand USD | -49.68% |
| 2012 | 938 Thousand USD | 72.14% |
| 2011 | 544.91 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 2.32 Million USD | -3.65% |
| 2002 | 2.41 Million USD | -2.7% |
| 2001 | 2.48 Million USD | -77.57% |
| 2000 | 11.07 Million USD | 56.04% |
| 1999 | 7.1 Million USD | 77.5% |
| 1998 | 4 Million USD | 19900.0% |
| 1997 | 20 Thousand USD | -60.0% |
| 1996 | 50 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 32.09 Million USD | 13.45% |
| 2023 Q4 | 23.88 Million USD | 28.96% |
| 2023 FY | 23.88 Million USD | 16.35% |
| 2023 Q1 | 19.87 Million USD | -3.18% |
| 2023 Q2 | 19.4 Million USD | -2.37% |
| 2023 Q3 | 18.52 Million USD | -4.55% |
| 2022 Q3 | 19.29 Million USD | 6.69% |
| 2022 Q4 | 20.52 Million USD | 6.41% |
| 2022 FY | 20.52 Million USD | 40.21% |
| 2022 Q1 | 16.31 Million USD | 11.43% |
| 2022 Q2 | 18.08 Million USD | 10.83% |
| 2021 Q2 | 13.17 Million USD | 8.17% |
| 2021 Q3 | 13.56 Million USD | 2.99% |
| 2021 Q1 | 12.17 Million USD | 26.93% |
| 2021 FY | 14.64 Million USD | 52.59% |
| 2021 Q4 | 14.64 Million USD | 7.91% |
| 2020 Q3 | 8.63 Million USD | 2.07% |
| 2020 FY | 9.59 Million USD | 20.62% |
| 2020 Q1 | 8.68 Million USD | 9.14% |
| 2020 Q2 | 8.45 Million USD | -2.57% |
| 2020 Q4 | 9.59 Million USD | 11.13% |
| 2019 Q4 | 7.95 Million USD | 15.81% |
| 2019 Q1 | 5.58 Million USD | 11.63% |
| 2019 Q2 | 6.06 Million USD | 8.59% |
| 2019 Q3 | 6.86 Million USD | 13.24% |
| 2019 FY | 7.95 Million USD | 58.96% |
| 2018 FY | 5 Million USD | -61.99% |
| 2018 Q4 | 5 Million USD | 16.24% |
| 2018 Q3 | 4.3 Million USD | 9.68% |
| 2018 Q1 | 14.66 Million USD | 11.35% |
| 2018 Q2 | 3.92 Million USD | -73.23% |
| 2017 Q2 | 9.68 Million USD | 29.66% |
| 2017 Q1 | 7.47 Million USD | 35.53% |
| 2017 FY | 13.16 Million USD | 138.89% |
| 2017 Q4 | 13.16 Million USD | 12.94% |
| 2017 Q3 | 11.65 Million USD | 20.37% |
| 2016 Q3 | 3.98 Million USD | 52.38% |
| 2016 Q2 | 2.61 Million USD | 94.32% |
| 2016 Q4 | 5.51 Million USD | 38.3% |
| 2016 Q1 | 1.34 Million USD | 213.79% |
| 2016 FY | 5.51 Million USD | 1184.96% |
| 2015 Q4 | 428.97 Thousand USD | -55.09% |
| 2015 Q3 | 955.17 Thousand USD | -47.64% |
| 2015 Q2 | 1.82 Million USD | 47.81% |
| 2015 Q1 | 1.23 Million USD | 13.75% |
| 2015 FY | 428.97 Thousand USD | -60.46% |
| 2014 Q1 | 227.02 Thousand USD | -51.9% |
| 2014 Q3 | 617.16 Thousand USD | 26.55% |
| 2014 FY | 1.08 Million USD | 129.89% |
| 2014 Q2 | 487.68 Thousand USD | 114.82% |
| 2014 Q4 | 1.08 Million USD | 75.8% |
| 2013 Q4 | 471.96 Thousand USD | -11.54% |
| 2013 Q2 | 181.33 Thousand USD | 141.78% |
| 2013 Q1 | 75 Thousand USD | -92.0% |
| 2013 Q3 | 533.51 Thousand USD | 194.22% |
| 2013 FY | 471.96 Thousand USD | -49.68% |
| 2012 Q2 | 163.13 Thousand USD | -20.86% |
| 2012 Q3 | 517.14 Thousand USD | 217.0% |
| 2012 Q4 | 938 Thousand USD | 81.38% |
| 2012 FY | 938 Thousand USD | 72.14% |
| 2012 Q1 | 206.13 Thousand USD | -62.17% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | 544.91 Thousand USD | 0.0% |
| 2011 Q4 | 544.91 Thousand USD | 83.88% |
| 2011 Q3 | 296.33 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | 523.89 Thousand USD | -81.5% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q1 | 2.83 Million USD | 21.54% |
| 2003 Q4 | 2.32 Million USD | -0.64% |
| 2003 Q1 | 2.39 Million USD | -1.01% |
| 2003 Q2 | 2.35 Million USD | -1.52% |
| 2003 Q3 | 2.34 Million USD | -0.53% |
| 2003 FY | 2.32 Million USD | -3.65% |
| 2002 Q4 | 2.41 Million USD | 0.85% |
| 2002 Q1 | 2.46 Million USD | -0.73% |
| 2002 FY | 2.41 Million USD | -2.7% |
| 2002 Q2 | 2.41 Million USD | -2.11% |
| 2002 Q3 | 2.39 Million USD | -0.73% |
| 2001 Q2 | 2.46 Million USD | -0.64% |
| 2001 Q1 | 2.47 Million USD | -77.63% |
| 2001 FY | 2.48 Million USD | -77.57% |
| 2001 Q4 | 2.48 Million USD | 1.85% |
| 2001 Q3 | 2.43 Million USD | -0.91% |
| 2000 Q3 | 10.91 Million USD | 29.43% |
| 2000 Q1 | 8.33 Million USD | 17.4% |
| 2000 FY | 11.07 Million USD | 56.04% |
| 2000 Q4 | 11.07 Million USD | 1.52% |
| 2000 Q2 | 8.43 Million USD | 1.15% |
| 1999 Q2 | 5.6 Million USD | 5.66% |
| 1999 FY | 7.1 Million USD | 77.5% |
| 1999 Q1 | 5.3 Million USD | 32.5% |
| 1999 Q3 | 6.2 Million USD | 10.71% |
| 1999 Q4 | 7.1 Million USD | 14.52% |
| 1998 Q2 | 500 Thousand USD | 4900.0% |
| 1998 FY | 4 Million USD | 19900.0% |
| 1998 Q1 | 10 Thousand USD | -75.0% |
| 1998 Q4 | 4 Million USD | 150.0% |
| 1998 Q3 | 1.6 Million USD | 220.0% |
| 1997 Q4 | 40 Thousand USD | -84.62% |
| 1997 FY | 20 Thousand USD | -60.0% |
| 1997 Q3 | 260 Thousand USD | 420.0% |
| 1997 Q2 | 50 Thousand USD | -98.84% |
| 1997 Q1 | 4.3 Million USD | 42900.0% |
| 1996 FY | 50 Thousand USD | 0.0% |
| 1996 Q4 | 10 Thousand USD | -99.75% |
| 1996 Q3 | 4 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -4963.232% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -37830.612% |
| Össur hf. | 467.73 Million USD | 95.134% |
| QHSLab, Inc. | 1.78 Million USD | -1177.446% |
| Wellstar International, Inc. | 51.36 Million USD | 55.695% |
| Össur hf. | 467.73 Million USD | 95.134% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | -4237.249% |
| Aurora Spine Corporation | 2.67 Million USD | -752.195% |
| BrainsWay Ltd. | 471 Thousand USD | -4731.925% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | -53.449% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 18.167% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -4484.692% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -12677.416% |
| Zecotek Photonics Inc. | 3.22 Million USD | -606.374% |
| Avitar, Inc. | 5.26 Million USD | -332.239% |
| Nanomix Corporation | 11.4 Million USD | -99.525% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | -336.149% |
| Theraclion SA | 1.95 Million EUR | -1066.655% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | -1173.172% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -1239.873% |
| Lombard Medical, Inc. | 32.29 Million USD | 29.523% |
| ALR Technologies Inc. | 19.26 Million USD | -18.138% |
| Stratec SE | 156.16 Million USD | 85.427% |
| Vycor Medical, Inc. | 1.11 Million USD | -1949.845% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -10774.342% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 98.66% |
| VMS Rehab Systems, Inc. | 133.52 USD | -17044812.373% |
| NewCardio, Inc. | 3 Million USD | -658.612% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -1005.849% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -3505.817% |
| Odyssey Group International, Inc. | 2.14 Million USD | -961.164% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -3296.771% |
| Wellness Center USA, Inc. | 4.04 Million USD | -463.05% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 28.755% |
| IR-Med Inc. | 161 Thousand USD | -14035.632% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -11698.38% |
| Polarean Imaging plc | 216.38 Thousand USD | -10417.534% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | -617.645% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -22658.367% |
| Capital Group Holdings, Inc. | 4944.00 USD | -460222.957% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -2746.009% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -9925.624% |
| Urologix, Inc. | 5.33 Million USD | -326.746% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | -494.108% |
| Nexeon MedSystems Inc. | 4.21 Million USD | -439.911% |
| SS Innovations International, Inc. | 8.21 Million USD | -176.921% |
| Qualis Innovations, Inc. | 9102.00 USD | -249936.992% |
| Smith & Nephew plc | 3.07 Billion USD | 99.261% |
| NIOX Group Plc | 1.4 Million USD | -1525.249% |
| Fuse Medical, Inc. | 1.99 Million USD | -1041.536% |
| Broncus Holding Corporation | 2.35 Million USD | -866.648% |
| Brain Scientific Inc. | 2.86 Million USD | -694.779% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -56174.089% |